PT89838A - Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana - Google Patents

Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana

Info

Publication number
PT89838A
PT89838A PT89838A PT8983889A PT89838A PT 89838 A PT89838 A PT 89838A PT 89838 A PT89838 A PT 89838A PT 8983889 A PT8983889 A PT 8983889A PT 89838 A PT89838 A PT 89838A
Authority
PT
Portugal
Prior art keywords
susceptivel
involvement
glycoprotein
preparing
complex
Prior art date
Application number
PT89838A
Other languages
English (en)
Other versions
PT89838B (pt
Inventor
James Arthos
Paul J Maddon
Richard Axel
Raymond W Sweet
Original Assignee
Univ Columbia
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia, Smithkline Beckman Corp filed Critical Univ Columbia
Publication of PT89838A publication Critical patent/PT89838A/pt
Publication of PT89838B publication Critical patent/PT89838B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/821—Separation of nucleic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT89838A 1988-02-24 1989-02-24 Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana PT89838B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/160,348 US5110906A (en) 1986-08-21 1988-02-24 Derivatives of soluble T-4

Publications (2)

Publication Number Publication Date
PT89838A true PT89838A (pt) 1989-10-04
PT89838B PT89838B (pt) 1994-02-28

Family

ID=22576514

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89838A PT89838B (pt) 1988-02-24 1989-02-24 Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana

Country Status (15)

Country Link
US (2) US5110906A (pt)
EP (1) EP0330227A3 (pt)
JP (1) JPH02503269A (pt)
KR (1) KR900700592A (pt)
AU (1) AU628072B2 (pt)
DE (1) DE330227T1 (pt)
DK (1) DK175816B1 (pt)
ES (1) ES2031805T1 (pt)
FI (1) FI102837B (pt)
GR (1) GR900300099T1 (pt)
HU (1) HU213019B (pt)
NZ (1) NZ228127A (pt)
PT (1) PT89838B (pt)
WO (1) WO1989008143A1 (pt)
ZA (1) ZA891456B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135747T1 (de) 1986-08-21 1996-04-15 Univ Columbia Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
US6673896B1 (en) * 1986-08-21 2004-01-06 The Trustees Of Columbia University In The City Of New York Derivatives of soluble T-4
US5958678A (en) * 1986-08-21 1999-09-28 The Trustees Of Columbia University In The City Of New York DNA encoding the T cell surface protein T4 and use of fragments of T4 in the treatment of AIDS
ZA887365B (en) * 1987-10-02 1990-05-30 Genentech Inc Adheson variants
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
US6710169B2 (en) 1987-10-02 2004-03-23 Genentech, Inc. Adheson variants
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
EP0432693A1 (en) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Liposomes cytotoxic to virus-infected cells
JPH0725794B2 (ja) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 新規なペプチド
EP0491888A4 (en) * 1990-05-25 1992-09-02 Biogen, Inc. Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
AU9028791A (en) * 1990-10-05 1992-04-28 President And Fellows Of Harvard College Detection and isolation of ligands
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
US6274134B1 (en) 1992-01-29 2001-08-14 National Institutes Of Health Human cell adhesion protein AAMP-1 and uses thereof
US5750394A (en) * 1994-05-20 1998-05-12 The Mount Sinai Medical Center Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
US5635351A (en) * 1995-03-14 1997-06-03 The Regents Of The University Of California Genetic gain and loss in gliomas
US6503703B1 (en) * 1995-05-19 2003-01-07 Mount Sinai School Of Medicine Of New York University Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
PT1003850E (pt) * 1997-06-06 2009-08-13 Dynavax Tech Corp Inibidores da actividade de sequências de adn imunoestimulantes
US6797462B1 (en) 1998-06-23 2004-09-28 Uab Research Foundation Cell-based assay for immunodeficiency virus infectivity and sensitivity
US6586207B2 (en) * 2000-05-26 2003-07-01 California Institute Of Technology Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
US7323174B1 (en) * 2000-06-12 2008-01-29 Arizona Board Of Regents On Behalf Of The University Of Arizona Modulation of immune response and methods based thereon
US7175988B2 (en) * 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
CA2454618C (en) 2001-07-24 2012-04-03 Biogen Idec Ma, Inc. Methods for treating or preventing sclerotic disorders using cd2-binding agents
US7368114B2 (en) * 2001-10-25 2008-05-06 The United States Of America As Represented By The Department Of Health And Human Services Fusion protein including of CD4
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
CA2565259A1 (en) 2004-05-07 2005-12-08 Astellas Us Llc Soluble lfa-3 polypeptide for treating viral disorders
US20080146495A1 (en) * 2005-03-11 2008-06-19 The Regents Of The University Of California Methods for Treating Hiv by Inhibiting Cd4 Down-Modulation
US20080283557A1 (en) * 2007-05-17 2008-11-20 Julianne Desautels Spout for food stuff container
US8912047B2 (en) * 2011-05-18 2014-12-16 Infineon Technologies Ag Method for producing a metal layer on a substrate and device
KR20130049671A (ko) 2011-11-04 2013-05-14 한미사이언스 주식회사 생리활성 폴리펩타이드 결합체 제조 방법
AR090281A1 (es) 2012-03-08 2014-10-29 Hanmi Science Co Ltd Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144983A (en) * 1981-02-27 1982-09-07 Otsuka Pharmaceut Factory Inc Preparation of physiologically active substance
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
ATE135747T1 (de) * 1986-08-21 1996-04-15 Univ Columbia Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
US5109123A (en) * 1988-06-14 1992-04-28 Dana Farber Cancer Institute Alteration of ability of soluble CD4 fragments to bind HIV

Also Published As

Publication number Publication date
AU4071889A (en) 1989-09-22
DK528289A (da) 1989-12-22
FI895049A0 (fi) 1989-10-24
US5422274A (en) 1995-06-06
HUT52814A (en) 1990-08-28
FI102837B1 (fi) 1999-02-26
DK175816B1 (da) 2005-03-07
US5110906A (en) 1992-05-05
AU628072B2 (en) 1992-09-10
GR900300099T1 (en) 1991-09-27
EP0330227A2 (en) 1989-08-30
FI102837B (fi) 1999-02-26
DK528289D0 (da) 1989-10-24
JPH02503269A (ja) 1990-10-11
PT89838B (pt) 1994-02-28
EP0330227A3 (en) 1991-01-30
KR900700592A (ko) 1990-08-16
WO1989008143A1 (en) 1989-09-08
DE330227T1 (de) 1990-09-27
HU213019B (en) 1997-01-28
NZ228127A (en) 1991-11-26
ZA891456B (en) 1990-01-31
ES2031805T1 (es) 1993-01-01

Similar Documents

Publication Publication Date Title
PT89838A (pt) Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana
PT84669B (pt) Processo para a preparacao de um medicamento para o tratamento de inflamacoes dos olhos contendo diclofenac-sodio
BR8801500A (pt) Processo de preparacao de um composito de matriz de vidro com fibra reforcada descontinua
PT90731A (pt) Processo para a preparacao de uma molecula de adn recombinante, de vacina para proteccao contra hiv e de diagnostico de exposicao a hiv
BR8700097A (pt) Processo para a preparacao de 2-oxo-1,3-dioxolanas e seu uso
IT1098440B (it) Preparati oftalmici e processo per la loro preparazione
PT84533B (pt) Processo para a preparacao de oxadiazois uteis no tratamento de demencia senil
PT90523A (pt) Processo para a preparacao de adsorvatos de ranitidina
PT86312A (pt) Processo para a preparacao de fibras superabsorventes
PT84273B (pt) Processo para a preparacao de derivados da dicloroanilina
PT93516A (pt) Processo para a preparacao de derivados de2-anilino-pirimidina uteis para controlar pragas
BR8707471A (pt) Vacina e processo de preparacao
PT90637A (pt) Processo de preparacao de polianidridos
BR8700912A (pt) Processo de preparacao de um sal de bario purificado
PT89946A (pt) Processo de preparacao de sulfatos ciclicos
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
PT92949A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano
PT84144B (pt) Processo para a preparacao de sulfonamidas heterociclicas uteis como agente antialergicos e antitromboticos
PT91363A (pt) Processo para a preparacao de uma emulsao transparente insecticida
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
PT92365A (pt) Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
BR8906223A (pt) Processo para preparar um clorofluorobenzeno ou difluorobenzeno
BR8704446A (pt) Processo para a preparacao de um hidrogel amplamente isento de monomeros
PT89204A (pt) Processo para a preparacao de um agente edulcorante
KR960001503B1 (en) Method for rdetecting antibodies to human immunodeficiency virus

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930802

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080204

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090224